Despite documented preclinical cardiometabolic benefits and favorable cross-sectional clinical associations, elevated concentrations of circulating adiponectin are associated with a significantly increased risk of incident ischemic stroke among women. This evidence concerns the gene ADIPOQ and ischemic stroke.